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Introduction

Hypothesis

BCT

Chronic cough (CC), a cough that lasts more
than eight weeks, is the number one complaint
of adults seeking non-emergent medical care1.
An estimated 20% of patients with CC do not
respond to medical treatment, and are said to
1-3
have refractory chronic cough (RCC) . Several
studies provide evidence that RCC is caused by
hypersensitivity of sensory protein receptors in
the airway epithelium known to regulate
cough1-12. The primary sensory receptors are
the transient receptor potential vanilloid
4-8
(TRPV) . These receptors can be found in the
epithelial layer of the bronchus, larynx and
9
nose . These receptors are very plastic; in other
words they are easily influenced by
endogenous and exogenous factors, such as
inflammation and chemical or mechanical
stimulation. Behavioral cough therapy (BCT),
which is provided by speech-language
pathologists, has been shown to result in
10-13
reduced cough sensitivity
. However, the
underlying mechanism that results in reduced
cough sensitivity is unknown.

The reduction in cough sensitivity is due to downmodulation of TRPV receptors through a
neuroplastic mechanism.

Cough Suppression Strategies
• Cough control breathing
• non-medicated lozenge
• sip water
• hard swallow
• breath hold

Implications
Examining the expression of TRPV
before and after BCT will potentially
explain the mechanism of the effect of
BCT, which may increase its application
in the clinic as well as open doors to
other potential treatments for RCC.

Taken from: https://gut.bmj.com/content/59/01/126

Methods
1. Obtain
biopsy of nose
and larynx
epithelial
tissue pre-BCT
5. Repeat
steps 1-4
post-BCT,
establish
methods

1.
2.

2. Analyze
TRPV protein
expression
and subtype
via Western

3.

4.
5.

6.
7.

8.
9.
10.

Taken from: http://www.guidetopharmacology.org/GRAC/FamilyIntroductionForward?familyId=78

Rationale

•
•

Establish feasible methods
Explore neuroplastic mechanism of
reducing cough hypersensitivity

VOICES (Voice Outcomes and Inquiry of
Cough and Essentials in Swallowing) Lab

4. Patients
complete
3-4 weeks
of BCT

3. Analyze
expression of
TRPV mRNA
via qPCR

11.

12.

13.
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